371 related articles for article (PubMed ID: 27979613)
1. Mucopolysaccharidosis IVA and glycosaminoglycans.
Khan S; Alméciga-Díaz CJ; Sawamoto K; Mackenzie WG; Theroux MC; Pizarro C; Mason RW; Orii T; Tomatsu S
Mol Genet Metab; 2017; 120(1-2):78-95. PubMed ID: 27979613
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
[TBL] [Abstract][Full Text] [Related]
3. Morquio A syndrome: diagnosis and current and future therapies.
Tomatsu S; Yasuda E; Patel P; Ruhnke K; Shimada T; Mackenzie WG; Mason R; Thacker MM; Theroux M; Montaño AM; Alméciga-Díaz CJ; Barrera LA; Chinen Y; Sly WS; Rowan D; Suzuki Y; Orii T
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1(0 1):141-51. PubMed ID: 25345096
[TBL] [Abstract][Full Text] [Related]
4. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
[TBL] [Abstract][Full Text] [Related]
5. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
[TBL] [Abstract][Full Text] [Related]
6. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).
Tomatsu S; Alméciga-Díaz CJ; Barbosa H; Montaño AM; Barrera LA; Shimada T; Yasuda E; Mackenzie WG; Mason RW; Suzuki Y; Orii KE; Orii T
Expert Opin Orphan Drugs; 2013 Oct; 1(10):805-818. PubMed ID: 25419501
[TBL] [Abstract][Full Text] [Related]
7. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
[TBL] [Abstract][Full Text] [Related]
8. Natural history of Morquio A patient with tracheal obstruction from birth to death.
Doherty C; Averill LW; Theroux M; Mackenzie WG; Pizarro C; Mason RW; Tomatsu S
Mol Genet Metab Rep; 2018 Mar; 14():59-67. PubMed ID: 29326877
[TBL] [Abstract][Full Text] [Related]
9. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
[TBL] [Abstract][Full Text] [Related]
10. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
Sawamoto K; Tomatsu S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
[TBL] [Abstract][Full Text] [Related]
11. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
[TBL] [Abstract][Full Text] [Related]
12. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder.
Yasuda E; Fushimi K; Suzuki Y; Shimizu K; Takami T; Zustin J; Patel P; Ruhnke K; Shimada T; Boyce B; Kokas T; Barone C; Theroux M; Mackenzie W; Nagel B; Ryerse JS; Orii KE; Iida H; Orii T; Tomatsu S
Mol Genet Metab; 2013 Jul; 109(3):301-11. PubMed ID: 23683769
[TBL] [Abstract][Full Text] [Related]
14. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
[TBL] [Abstract][Full Text] [Related]
15. Characterization of disease-specific chondroitin sulfate nonreducing end accumulation in mucopolysaccharidosis IVA.
Lawrence R; Prill H; Vachali PP; Adintori EG; de Hart G; Wang RY; Burton BK; Pasquali M; Crawford BE
Glycobiology; 2020 Jul; 30(7):433-445. PubMed ID: 31897472
[TBL] [Abstract][Full Text] [Related]
16. Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study.
Leong HY; Abdul Azize NA; Chew HB; Keng WT; Thong MK; Mohd Khalid MKN; Hung LC; Mohamed Zainudin N; Ramlee A; Md Haniffa MA; Yakob Y; Ngu LH
Orphanet J Rare Dis; 2019 Jun; 14(1):143. PubMed ID: 31200731
[TBL] [Abstract][Full Text] [Related]
17. [Natural history of Morquio A disease].
Baujat G; Valayannopoulos V
Arch Pediatr; 2014 Jun; 21 Suppl 1():S32-8. PubMed ID: 25063382
[TBL] [Abstract][Full Text] [Related]
18. A novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re-evaluating primer sequences.
Kim SM; Noh ES; Park JH; Park HD; Lee SY; Jang JH; Cho SY
Ann Hum Genet; 2022 Nov; 86(6):361-368. PubMed ID: 36000290
[TBL] [Abstract][Full Text] [Related]
19. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
Tomatsu S; Sawamoto K; Alméciga-Díaz CJ; Shimada T; Bober MB; Chinen Y; Yabe H; Montaño AM; Giugliani R; Kubaski F; Yasuda E; Rodríguez-López A; Espejo-Mojica AJ; Sánchez OF; Mason RW; Barrera LA; Mackenzie WG; Orii T
Drug Des Devel Ther; 2015; 9():1937-53. PubMed ID: 25897204
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]